Microglial activation is required for Aβ clearance after intracranial injection of lipopolysaccharide in APP transgenic mice

Journal of Neuroimmune Pharmacology

Volumn 2, Issue 2, 2007, Pages 222-231

  Herber, Donna L ^a,b   Mercer, Mary ^a   Roth, Lisa M ^a   Symmonds, Keisha ^a   Maloney, Jessica ^a   Wilson, Nedda ^a   Freeman, Melissa J ^a   Morgan, Dave ^a   Gordon, Marcia N ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

CD45; Complement receptor 3; Dexamethasone; Fc receptor; Macrosialin (CD68); Scavenger receptor class A

Indexed keywords

AMYLOID BETA PROTEIN; AUTACOID; LIPOPOLYSACCHARIDE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; HIPPOCAMPUS; HUMAN; INFLAMMATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; METABOLISM; MICROGLIA; MOUSE; PATHOLOGY; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN; ANIMALS; HIPPOCAMPUS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENTRICULAR; LIPOPOLYSACCHARIDES; METABOLIC CLEARANCE RATE; MICE; MICE, TRANSGENIC; MICROGLIA;

EID: 34247502763     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-007-9069-z     Document Type: Article

References (36)

1. Aisen PS, Davis KL, Berg JD, Schafer K, Campbell K, Thomas RG, Weiner MF, Farlow M R, Sano M, Grundman M, Thall LJ (2000) A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study, Neurology 54:588-593
2. Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thall LJ (2003) Effects of rofecoxib or naproven vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289:2819-2826
3. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, et al. (2000) Inflammation and Alzheimer's disease, Neurobiol Aging 21:383-421
4. Ard MD, Cole GM, Wei J, Mehrle AP, Fratkin JD (1996) Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J Neurosci Res 43:190-202
5. Breitner JC, Zandi PP (2001) Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer's disease? N Engl J Med 345:1567-1568
6. DiCarlo G, Wilcock D, Henderson D, Gordon M, Morgan D (2001) Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice. Neurobiol Aging 22:1007-1012
7. Felts PA, Woolston AM, Fernando HB, Asquith S, Gregson NA, Mizzi OJ, Smith KJ (2005) Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain 128:1649-1666
8. Gordon MN, Schreier WA, Ou X, Holcomb LA, Morgan DG (1997) Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat, J Comp Neurol 388:106-119
9. Green KN, Billings LM, Roozendaal B, McGaugh J, LaFerla FM (2006) Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci 26:9047-9056
10. Hardman JG, Limbird LE, Oilman AG (2001) The pharmacological basis of therapeutics, 10th edition. McGraw-Hill Medical Publishing, New York, NY
11. Herber DL, Roth LM, Wilson D, Wilson N, Mason JE, Morgan D, Gordon MN (2004) Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice. Exp Neurol 190:245-253
12. Herber DL, Maloney JL, Roth LM, Freeman MJ, Morgan D, Gordon MN (2006) Diverse microglial responses after intrahippocampal administration of lipopolysaccharide. Glia 55:382-391
13. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4:97-100
14. Husemann J, Loike JD, Anankov R, Febbraio M, Silverstein SC (2002) Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 40:195-205
15. Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN (2002) Microglial activation and β-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J Neurosci 22:2246-2254
16. Knight KR, Vairo G, Hamilton JA (1992) Regulation of pinocytosis in murine macrophages by colony-stimulating factors and other agents. J Leukoc Biol 51:350-359
17. Koenigsknecht J, Landreth G (2004) Microglial phagocytosis of fibrillar β-amyloid through a β1 integrin-dependent mechanism. J Neurosci 24:9838-9846
18. Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, Cole GM (2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 20:5709-5714
19. Malm TM, Koistinaho M, Parepalo M, Vatanen T, Ooka A, Karlsson S, Koistinaho J (2005) Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis 18:134-142
20. Mandrekar SD, Jiang Q, Reed-Geahan E, Landreth GA (2007) Microglia mediate the clearance of soluble amyloid beta through pinocytic mechanisms. Program number 270.8, Society for Neuroscience, 2006 Online
21. Morgan D, Gordon MN, Tan J, Wilcock D, Rojiani A (2005) Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J Neuropathol Exp Neurol 64:743-753
22. Nadeau S, Rivest S (2003) Glucocorticoids play a fundamental role in protecting the brain during innate immune response. J Neurosci 23:5536-5544
23. Palsson-McDermott EM, O'Neill LA (2004) Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4, Immunology 113:153-162
24. Pan J, Ju D, Wang Q, Zhang M, Xia D, Zhang L, Yu H, Cao X (2001) Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. J Immunol Lett 76:153-161
25. Qiao X, Cummins DJ, Paul SM (2001) Neuroinflammation-induced acceleration of amyloid deposition in the APPV717F transgenic mouse. Eur J Neurosci 14:474-482
26. Quinn J, Montine T, Morrow J, Woodward WR, Kulhanek D, Eckenstein F (2003) Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease. J Neuroimmunol 137:32-41
27. Reines SA, Block GA, Morris JC, Liu G, Nessly ML, Lines CR, Norman BA, Baranak CC (2004) Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study. Neurology 62:66-71
28. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173-177
29. Sheng JG, Bora SH, Xu G, Borchelt DR, Price DL, Koliatsos VE (2003) Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol Dis 14:133-145
30. Sly LM, Krzesicki RF, Brashler JR, Buhl AE, McKinley DD, Carter DB, Chin JE (2001) Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease. Brain Res Bull 56:581-588
31. Szczepanik AM, Ringheim GE (2003) IL-10 and glucocorticoids inhibit Abeta(1-42)- and lipopolysaccharide-induced pro-inflammatory cytokine and chemokine induction in the central nervous system, J Alzheimers Dis 5:105-117
32. Tanaka J, Fujita H, Matsuda S, Toku K, Sakanaka M, Maeda N (1997) Glucocorticoid- and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids. Glia 20:23-27
33. Webster SD, Yang AJ, Margol L, Garzon-Rodriguez W, Glabe CG, Tamer AJ (2000) Complement component Clq modulates the phagocytosis of Abeta by microglia. Exp Neurol 161:127-138
34. Wilcock DM, DiCarlo G, Henderson D, Jackson J, Clarke K, Ugen KE, Gordon MN, Morgan D (2003) Intracranially administered anti-Aβ antibodies reduce β-amyloid deposition by mechanisms independent of and associated with microglial activation. J Neurosci 213:3745-3751
35. Wilcock DM, Munireddy SK, Rosenthal A, Ugen KE, Gordon MN, Morgan D (2004) Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration. Neurobiol Dis 15:11-20
36. Woods AG, Poulsen FR, Gall CM (1999) Dexamethasone selectively suppresses microglial trophic responses to hippocampal deafferentation. Neuroscience 91:1277-1289